JANSSEN CILAG FARMACEUTICA, LDA. secures contract for Acquisition Of Ustecinumab Biosimilars [90 Mg; Sun Inj; Syringe]

Portugal, Dec. 12 -- Portugal based JANSSEN CILAG FARMACEUTICA, LDA. has secured contract from Unidade Local De Saude Do Estuario Do Tejo, E. P. E. for Acquisition Of Ustecinumab Biosimilars [90 Mg; Sun Inj; Syringe]. The value of the contract is worth 3605550 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....